001     190223
005     20210129215535.0
024 7 _ |2 doi
|a 10.3402/fnr.v59.26407
024 7 _ |2 Handle
|a 2128/8972
024 7 _ |2 WOS
|a WOS:000354054800001
024 7 _ |a altmetric:3954037
|2 altmetric
037 _ _ |a FZJ-2015-03147
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-HGF)0
|a Hildebrand, P.
|b 0
245 _ _ |a Effects of dietary tryptophan and phenylalanine-tyrosine depletion on phasic alertness in healthy adults - A pilot study
260 _ _ |a Häggeby [u.a.]
|b Co-Action Publishing
|c 2015
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1437369607_27749
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |2 DRIVER
|a article
520 _ _ |a Background: The synthesis of the neurotransmitters serotonin (5-HT) and dopamine (DA) in the brain can be directly altered by dietary manipulation of their relevant precursor amino acids (AA). There is evidence that altered serotonergic and dopaminergic neurotransmission are both associated with impaired attentional control. Specifically, phasic alertness is one specific aspect of attention that has been linked to changes in 5-HT and DA availability in different neurocircuitries related to attentional processes. The present study investigated the impact of short-term reductions in central nervous system 5-HT and DA synthesis, which was achieved by dietary depletion of the relevant precursor AA, on phasic alertness in healthy adult volunteers; body weight–adapted dietary tryptophan and phenylalanine–tyrosine depletion (PTD) techniques were used.Methods: The study employed a double-blind between-subject design. Fifty healthy male and female subjects were allocated to three groups in a randomized and counterbalanced manner and received three different dietary challenge conditions: acute tryptophan depletion (ATD, for the depletion of 5-HT; N=16), PTD (for the depletion of DA; N=17), and a balanced AA load (BAL; N=17), which served as a control condition. Three hours after challenge intake (ATD/PTD/BAL), phasic alertness was assessed using a standardized test battery for attentional performance (TAP). Blood samples for AA level analyses were obtained at baseline and 360 min after the challenge intake.Results: Overall, there were no significant differences in phasic alertness for the different challenge conditions. Regarding PTD administration, a positive correlation between the reaction times and the DA-related depletion magnitude was detected via the lower plasma tyrosine levels and the slow reaction times of the first run of the task. In contrast, higher tryptophan concentrations were associated with slower reaction times in the fourth run of the task in the same challenge group.Conclusion: The present study is the first to demonstrate preliminary data that support an association between decreased central nervous system DA synthesis, which was achieved by dietary depletion strategies, and slower reaction times in specific runs of a task designed to assess phasic alertness in healthy adult volunteers; these findings are consistent with previous evidence that links phasic alertness with dopaminergic neurotransmission. A lack of significant differences between the three groups could be due to compensatory mechanisms and the limited sample size, as well as the dietary challenge procedures administered to healthy participants and the strict exclusion criteria used. The potential underlying neurochemical processes related to phasic alertness should be the subject of further investigations.
536 _ _ |0 G:(DE-HGF)POF3-572
|a 572 - (Dys-)function and Plasticity (POF3-572)
|c POF3-572
|f POF III
|x 0
700 1 _ |0 P:(DE-HGF)0
|a Königschulte, W.
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Gaber, T. J.
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Bubenzer-Busch, S.
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Helbold, K.
|b 4
700 1 _ |0 P:(DE-HGF)0
|a Biskup, C. S.
|b 5
700 1 _ |0 P:(DE-Juel1)131777
|a Langen, Karl-Josef
|b 6
700 1 _ |0 P:(DE-Juel1)131720
|a Fink, Gereon Rudolf
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Zepf, F. D.
|b 8
|e Corresponding author
773 _ _ |0 PERI:(DE-600)2418338-6
|a 10.3402/fnr.v59.26407
|p 26407
|t Food & nutrition research
|v 59
|x 1654-661X
|y 2015
856 4 _ |u https://juser.fz-juelich.de/record/190223/files/26407-158743-1-PB.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/190223/files/26407-158743-1-PB.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/190223/files/26407-158743-1-PB.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/190223/files/26407-158743-1-PB.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/190223/files/26407-158743-1-PB.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/190223/files/26407-158743-1-PB.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:190223
|p openaire
|p open_access
|p driver
|p VDB
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-HGF)0
|a Forschungszentrum Jülich GmbH
|b 3
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-HGF)0
|a Forschungszentrum Jülich GmbH
|b 5
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131777
|a Forschungszentrum Jülich GmbH
|b 6
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131720
|a Forschungszentrum Jülich GmbH
|b 7
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-HGF)0
|a Forschungszentrum Jülich GmbH
|b 8
|k FZJ
913 0 _ |0 G:(DE-HGF)POF2-333
|1 G:(DE-HGF)POF2-330
|2 G:(DE-HGF)POF2-300
|a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
913 1 _ |0 G:(DE-HGF)POF3-572
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2015
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
915 _ _ |0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
|a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b FOOD NUTR RES : 2013
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)1060
|2 StatID
|a DBCoverage
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a FullTexts
980 1 _ |a FullTexts
981 _ _ |a I:(DE-Juel1)INM-4-20090406


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21